NeuroWorks 2026 - Scalable Neurotechnology: Innovation, Translation and Transformative Treatments

Neurotech is developing rapidly, with devices offering more precision and greater potential for scaling. Our flagship forum will provide a focused examination of the field’s direction by showcasing cutting-edge technological advances, as well as highlighting the importance of aligning clinical needs early in the development of technologies. 

Entry in neurotech and translation pathways will be signposted through first-hand accounts of journeys and by highlighting ARIA calls, Cambridge NeuroWorks programming and further funding opportunities, plus investment perspectives.  

This forum aims to drive insight and collaboration across disciplines by purposeful exchanges with structured networking, informal discussions, and showcases selected from offered contributions from across the UK-neurotech ecosystem.  

This highly interactive meeting will provide an in-depth exploration of neurotech through a mix of keynote presentations, panel discussions, problem-solving sessions and contributed showcases.

Confirmed speakers include:

Harith Akram - Neurosurgeon and Honorary Clinical Associate Professor - UCL/ UCLH
Luke Bashford - Scientific Director, National Centre for Neurotechnology and Neurorestoration Lecturer, Neuroscience and Neurotechnology, Newcastle University and Newcastle Hospitals NHS Foundation Trust
Andrew Jackson - Professor of Neural Interfaces - Newcastle University
Katja Kornysheva - Associate Professor in Human Neuroscience UKRI Future Leaders Fellow - University of Birmingham
Zoe Kourtzi - Professor of Experimental Psychology at the University of Cambridge
Tamar Makin - Professor of Cognitive Neuroscience, University of Cambridge
Anne Vanhoestenberge - King’s College London & MAISI

Who should attend? 

This forum is open to participants from across the UK, based in multiple sectors, including neuroscience, engineering, clinical practice, investment, and advanced technology.  We also welcome those with relevant skills keen to enter neurotech, such as game developers, ML researchers, as well as patients and family members with first-hand experience of clinical need keen to connect with innovators or funders.